2-Octylcyclopentanone Inhibits Beta Lactam Resistant Diabetic Wound Pathogens

Trop Life Sci Res. 2023 Mar;34(1):279-291. doi: 10.21315/tlsr2023.34.1.15. Epub 2023 Mar 31.

Abstract

Microbial infection is a frequent complication of diabetic foot ulcers, with up to 82% of ulcers being infected at the initial stage of diabetes. Furthermore, the emergence of beta lactam resistant pathogens managed to eliminate the use of beta lactam antibiotics as a chemotherapeutic alternative. This further increases the amputation and mortality rate. Hence, the aim of this study is to evaluate antimicrobial efficacy of a ketone derivative 2-octylcyclopentanone against diabetic wound pathogens. The inhibitory activity of the compound was determined using disc diffusion and broth microdilution assay. Generally, 2-octylcyclopentanone showed broad-spectrum antimicrobial activity, particularly against beta lactam resistant pathogens. The compound showed comparably better antimicrobial activity than all reference antibiotics, including chloramphenicol, streptomycin, ampicillin and penicillin. In addition, the same compound also inhibits a clinically isolated Pseudonomas aeruginosa that was resistant to all reference antibiotics. The activity was microbicidal based on the low minimal lethality concentration recorded, particularly on MRSA, P. aeruginosa and Candida utilis. The killing efficiency of the compound was concentration dependent. During kill curve analysis, the inhibitory activity of 2-octylcyclopentanone was concentration and time-dependent. 99.9% of reduction of bacterial growth was observed. MRSA and P. aeruginosa, two significant diabetic wound infections, are totally inhibited by the molecule at a concentration of minimum lethality concentration. In short, 2-octylcyclopentanone exhibited significant inhibitory towards wide range of diabetic wound pathogens. Which is considered crucial since it will provide a safe and effective alternative treatment for diabetic ulcer infection.

Jangkitan mikrob adalah komplikasi ulser yang kerap dijangkiti pada kaki pesakit diabetes, yang boleh mencapai sehingga 82% jangkitan pada peringkat awal diabetes. Kemunculan patogen tahan beta laktam berjaya menghapuskan penggunaan antibiotik beta laktam sebagai alternatif kemoterapi. Ini meningkatkan lagi kadar amputasi dan kematian. Oleh itu, tujuan kajian ini adalah untuk menilai keberkesanan antimikrob bagi derivatif keton 2-octylcyclopentanone terhadap patogen luka diabetes. Aktiviti perencatan sebatian ditentukan menggunakan resapan cakera dan ujian cerakinan mikrodilusi. Secara amnya, 2-octylcyclopentanone menunjukkan aktiviti antimikrob spektrum luas, terutamanya terhadap patogen tahan beta laktam. Kompaun tersebut menunjukkan aktiviti antimikrob yang lebih baik berbanding semua antibiotik rujukan, termasuk kloramfenikol, streptomisin, ampisilin dan penisilin. Di samping itu, sebatian yang sama juga menghalang Pseudonomas aeruginosa yang diasingkan secara klinikal yang tahan terhadap semua antibiotik rujukan. Aktiviti ini adalah mikrobisida berdasarkan kepekatan kematian minimum yang rendah yang direkodkan, terutamanya pada MRSA, P. aeruginosa dan Candida utilis. Kecekapan membunuh kompaun adalah bergantung kepada kepekatan. Semasa analisis keluk bunuh, aktiviti perencatan 2-octylcyclopentanone adalah kepekatan dan bergantung kepada masa. 99.9% pengurangan pertumbuhan bakteria diperhatikan. MRSA dan P. aeruginosa, dua jangkitan luka diabetes yang ketara, dihalang sepenuhnya oleh molekul pada kepekatan kepekatan maut minimum. Ringkasnya, 2-octylcyclopentanone menunjukkan perencatan yang ketara terhadap pelbagai patogen luka diabetes. Yang dianggap penting kerana ia akan menyediakan rawatan alternatif yang selamat dan berkesan untuk jangkitan ulser diabetik.

Keywords: 2-Octylcyclopentanone; Aktiviti Antimikrobial; Antimicrobial Activity; Beta Lactam Resistance; Diabetic Foot Ulcer; Diabetic Wound Infection; Jangkitan Luka Diabetes; Ketahanan Beta Laktam; Ulser Kaki Diabetes.